Kezar investor relations
Web31 dec. 2024 · Kezar Life Sciences is a clinical-stage biopharmaceutical company discovering and developing novel treatments for immune-mediated and oncologic … Web18 jan. 2024 · Investor Relations. Company Overview; Press Releases; Events & Presentations; Corporate Governance. Governance Documents; Board of Directors; …
Kezar investor relations
Did you know?
WebUtilizing the team’s deep scientific expertise, Kezar is developing novel, first-in-class, small molecule approaches for targeting select proteins to regulate cellular function. These …
WebKZR Kezar Life Sciences, Inc. Common Stock (KZR) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Pre-Market Charts Key Data Bid Price and Ask … Web5 okt. 2024 · SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing …
WebKezar Life Sciences : Appoints Gitanjali Jain as Vice President, Investor Relations and External Affairs. Published: 2024-10-05 16:03:02 ET KZR. Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today … Web9 nov. 2024 · Read about Kezar Life Sciences Inc (KZR: ... Investor Relations ... Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams.
Web3 nov. 2024 · Gitanjali Jain Vice President, Investor Relations and External Affairs 650-269-7523 [email protected] Kimberly Minarovich Argot Partners 212-600-1902 [email protected] Site Navigation
WebEvents and Presentations Alnylam Pharmaceuticals, Inc. EVENTS & PRESENTATIONS Upcoming Events There are no upcoming events at this time. Please check again soon. … install bathroom fan denverWeb13 apr. 2024 · Company profile for Kezar Life Sciences, Inc. (KZR) with a description, list of executives, contact details and other key facts. Skip to main content. Log In Free Trial. Home. ... Vice President of Investor Relations and External Affairs: Mark Schiller: Senior Vice President of Legal Affairs: jewish synagogue shooting pittsburghWeb5 okt. 2024 · Kezar Life Sciences, Inc. (NASDAQ:KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and... install bathroom fan and lightWeb5 okt. 2024 · -- Kezar Life Sciences said Tuesday it named Gitanjali Jain vice president of investor relations and external affairs. Jain previously was managing director at … jewish synagogues in baltimoreWeb5 okt. 2024 · -- Kezar Life Sciences said Tuesday it named Gitanjali Jain vice president of investor relations and external affairs. Jain previously was managing director at Solebury Trout, according to the... April 2, 2024 jewish synagogues denverWeb14 apr. 2024 · The average price point forecasted by analysts for Kezar Life Sciences Inc. (KZR) is $16.67, which is $15.04 above the current market price. The public float for KZR is 54.06M, and currently, short sellers hold a 9.81% ratio of that float. The average trading volume of KZR on April 14, 2024 was 940.42K shares. KZR’s Market Performance jewish synagogues in edinburgh scotlandWeb17 mrt. 2024 · Kezar Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update March 17, 2024, 1:01 PM · 12 min read Topline data from two Phase 2 trials of KZR-616 expected in... jewish synagogues in cincinnati ohio